Nakamura Toru, Hirano Satoshi, Noji Takehiro, Asano Toshimichi, Okamura Keisuke, Tsuchikawa Takahiro, Murakami Soichi, Kurashima Yo, Ebihara Yuma, Nakanishi Yoshitsugu, Tanaka Kimitaka, Shichinohe Toshiaki
Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Ann Surg Oncol. 2016 Dec;23(Suppl 5):969-975. doi: 10.1245/s10434-016-5493-8. Epub 2016 Aug 5.
Recently, distal pancreatectomy with en bloc celiac axis resection (DP-CAR) or modified Appleby procedure for locally advanced pancreatic body cancer is increasingly reported. However, actual long-term survival data are still unknown.
This study retrospectively reviewed 80 consecutive patients with pancreatic body cancer who underwent DP-CAR at a single institution.
The study included 40 men and 40 women with a median age of 65 years (range, 44-85 years). A pancreatic fistula was the most common complication, occurring in 47 patients (57.5 %). Other complications with a high incidence were ischemic gastropathy (23 patients, 28.8 %) and delayed gastric emptying (20 patients, 25 %). According to the Clavien-Dindo classification, the major complications, defined as complications of grade 3 or higher, were observed in 33 patients (41.3 %), and the in-hospital mortality involved four patients (5 %). For all 80 patients, the 1-, 2-, and 5-year overall survivals (OSs) were respectively 81.1, 56.9, and 32.7 %, and the median survival time was 30.9 months. The actual 5-year survival for the 61 patients whose surgery was performed five or more years earlier was 27.9 % (17 of 61). The 1-, 2-, and 5-year OSs for the patients who underwent preoperative therapy (100, 90, and 78.8 %) were significantly better than for those who underwent upfront surgery (77.9, 51.5, and 26.7 %; P < 0.0001).
The findings show DP-CAR to be a valid procedure for treating locally advanced pancreatic body cancer, which might contribute more to patients' survival when performed as part of multidisciplinary treatment.
最近,越来越多的报道称对局部晚期胰体癌采用联合腹腔干整块切除的远端胰腺切除术(DP-CAR)或改良的Appleby手术。然而,实际的长期生存数据仍然未知。
本研究回顾性分析了在单一机构接受DP-CAR的80例连续胰体癌患者。
该研究纳入了40名男性和40名女性,中位年龄为65岁(范围44 - 85岁)。胰瘘是最常见的并发症,发生在47例患者中(57.5%)。其他高发生率的并发症包括缺血性胃病(23例患者,28.8%)和胃排空延迟(20例患者,25%)。根据Clavien-Dindo分类,3级及以上并发症定义为主要并发症,在33例患者中观察到(41.3%),住院死亡率为4例患者(5%)。对于所有80例患者,1年、2年和5年总生存率(OS)分别为81.1%、56.9%和32.7%,中位生存时间为30.9个月。61例手术时间在5年或更早之前的患者的实际5年生存率为27.9%(61例中的17例)。接受术前治疗的患者的1年、2年和5年OS(分别为100%、90%和78.8%)显著优于接受直接手术的患者(分别为77.9%、51.5%和26.7%;P < 0.0001)。
研究结果表明DP-CAR是治疗局部晚期胰体癌的有效手术,作为多学科治疗的一部分进行时可能对患者生存有更大贡献。